Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T20:36:59.423Z.
Calculation as of: 2026-10-06T20:36:59.423Z.
Quote observation: 2026-10-06T18:36:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e63b0f3351cfb4e99b55b76d8265d9a833d2605075c67dfdbe278579742c9cb6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-05-31.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$2.71M
Price/OCF Ratio
5.06
TTM Avg
16.55
3Y Avg
669.72
5Y Avg
669.72
Market Cap
$3.00M
Price/OCF Ratio
N/A
TTM Avg
93.37
3Y Avg
1547.51
5Y Avg
1547.51
Market Cap
$2.37M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.33M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intelligent Group Limited (INTJ) | $2.74M | N/A | N/A | N/A | N/A |
| Globavend Holdings Limited (GVH)vs › | $2.71M | 5.06 | 16.55 | 669.72 | 669.72 |
| Top KingWin Ltd. Class A (DPU)vs › | $2.66M | N/A | N/A | N/A | N/A |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.64M | N/A | N/A | N/A | N/A |
| PTL Limited (PTLE)vs › | $2.98M | N/A | N/A | N/A | N/A |
| BioNexus Gene Lab Corp. (BGLC)vs › | $3.00M | N/A | 93.37 | 1547.51 | 1547.51 |
| DirectBooking Technology Co., Ltd. (ZDAI)vs › | $2.37M | N/A | N/A | N/A | N/A |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.33M | N/A | N/A | N/A | N/A |
| Iveda Solutions, Inc. (IVDA)vs › | $3.17M | N/A | N/A | N/A | N/A |
| Polar Power, Inc. (POLA)vs › | $3.17M | N/A | 810.88 | 810.88 | 810.88 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2024-05-31 | 1.85 |
| 2024-05-30 | 1.99 |
| 2024-05-29 | 2.07 |
| 2024-05-28 | 2.14 |
| 2024-05-24 | 2.28 |
| 2024-05-23 | 2.35 |
| 2024-05-22 | 2.65 |
| 2024-05-21 | 2.50 |
| 2024-05-20 | 2.03 |
| 2024-05-17 | 1.90 |
| 2024-05-16 | 1.85 |
| 2024-05-15 | 1.85 |
| 2024-05-14 | 1.97 |
| 2024-05-13 | 1.86 |
| 2024-05-10 | 1.84 |
| 2024-05-09 | 1.86 |
| 2024-05-08 | 1.95 |
| 2024-05-07 | 1.85 |
| 2024-05-06 | 1.86 |
| 2024-05-03 | 1.93 |
| 2024-05-02 | 2.12 |
| 2024-05-01 | 1.95 |
| 2024-04-30 | 1.84 |
| 2024-04-29 | 1.97 |
| 2024-04-26 | 2.48 |
| 2024-04-25 | 2.50 |
| 2024-04-24 | 2.64 |
| 2024-04-23 | 2.84 |
| 2024-04-22 | 2.79 |
| 2024-04-19 | 2.98 |
| 2024-04-18 | 2.94 |
| 2024-04-17 | 3.00 |
| 2024-04-16 | 3.11 |
| 2024-04-15 | 3.13 |
| 2024-04-12 | 3.17 |
| 2024-04-11 | 3.30 |
| 2024-04-10 | 3.45 |
| 2024-04-09 | 3.41 |
| 2024-04-08 | 2.96 |
| 2024-04-05 | 3.05 |
| 2024-04-04 | 3.09 |
| 2024-04-03 | 3.28 |
| 2024-04-02 | 3.24 |
| 2024-04-01 | 3.66 |
